Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue.
Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg
Availability: In Stock

Store in a cool & dry place, keep away from strong light and heat.

[1]. Zhu YX, et al. Molecular mechanism of action of the immune-modulatory drugs, thalidomide, lenalidomide and pomalidomide in multiple myeloma. Leukemia & Lymphoma. 2013 Apr;54(4):683-7. [2]. Hernandez-Ilizaliturri FJ, et al. Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model. Clinical Cancer Research. 2005 Aug 15;11(16):5984-92. [3]. Schafer PH, et al. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs. The Journal of Pharmacology and Experimental Therapeutics. 2003 Jun;305(3):1222-32. [4]. Li Z, et al. Pomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models. PloS One. 2013 Aug 5;8(8):e71754. [5]. Lu J, et al. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 2015 Jun 18;22(6):755-63. [6]. Liu D, et al. Tumour necrosis factor-α inhibits hepatic lipid deposition through GSK-3β/β-catenin signaling in juvenile turbot (Scophthalmus maximus L.). General and Comparative Endocrinology. 2016 Mar 1;228:1-8.